Fair Prescription Drug Prices for Americans Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Fair Prescription Drug Prices for Americans Act
This bill caps the price of drugs and biologics at the average price among certain countries.
Specifically, the retail list price of a drug or biologic in the United States may not exceed the average retail list price among Canada, France, Germany, Italy, Japan, and the United Kingdom. The Department of Health and Human Services (HHS) must calculate the average price in these countries based on data that is submitted by manufacturers directly to HHS and on publicly filed materials from manufacturers.
Manufacturers who violate the bill's price cap are subject to civil penalties.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1218: Fair Prescription Drug Prices for Americans Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-1218/
"S. 1218: Fair Prescription Drug Prices for Americans Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-1218/.
S. 1218, 118th Cong. (2026), https://openamerica.io/bill/118-S-1218/.
[S. 1218: Fair Prescription Drug Prices for Americans Act](https://openamerica.io/bill/118-S-1218/)